Original researchMortality and Morbidity After Transmetatarsal Amputation: Retrospective Review of 101 Cases
Section snippets
Materials and Methods
Medical charts and electronic databases were retrospectively reviewed for 108 patients seen consecutively for TMA. Surgery was performed by the senior authors at Kaiser Permanente Oakland, Richmond, and Walnut Creek, between April 1993 and January 2004. Outcome assessments were performed by the senior authors at the last documented office visit.
Indications for surgery were chronic forefoot ulceration (Fig 1A), forefoot infection, forefoot gangrene (Fig 1B), or a combination of these (Table 1).
Results
Demographic characteristics and risk factors for the TMA surgery cohort are shown in Table 2. Mean postoperative follow-up, excluding patients who died or went on to a more proximal amputation less than 6 months after TMA, was 2.1 years. The TMA was done in 101 feet for 91 patients (78 men, 23 women with mean age of 64.3 years [range 39 to 86 years]).
Palpable pedal pulses were noted in 34 patients. Of patients without a palpable pulse, 36 had an audible Doppler signal. Mean ABI was 0.73 (range
Discussion
Bernard and Heute first described TMA in 1855 for treatment of trenchfoot. However, the TMA limb salvage procedure was not popularized until 1949, when McKittrick and colleagues (8) first reported a series of 215 TMA procedures done to treat infection or gangrene in patients with diabetes mellitus. These investigators reported a healing rate of 72%, a 12.5% rate of amputation higher on the limb, postoperative hospital stay of 30 days, and a 0.9% rate of hospital mortality within 30 days after
Conclusion
The current study describes morbidity and mortality after TMA in a large population of diabetic and vasculopathic patients. The diagnosis of ESRD was found to be a statistically significant predictor for failure to heal. Patients with a palpable pedal pulse had statistically significant predictable healing as well as not requiring a more proximal amputation. Therefore, we believe that these factors should be considered when counseling patients about potential risks and benefits of TMA.
Acknowledgments
Kaiser Permanente Division of Research Biostatistician and Investigator Mary Anne Armstrong, MA, provided statistical consultation, and Yun-Yi Hung, PhD, Programmer, ran all the analyses. The Kaiser Permanente Medical Editing Department provided editorial review and assistance.
References (28)
- et al.
Transmetatarsal amputation in patients with peripheral vascular disease
Eur J Vasc Surg
(1991) - et al.
Outcomes of transmetatarsal amputations in patients with diabetes mellitus
J Foot Ankle Surg
(1997) - et al.
Transmetatarsal amputationthe role of adjunctive revascularization
J Vasc Surg
(1991) - et al.
Incidence of skin breakdown and higher amputation after transmetatarsal amputationimplications for rehabilitation
Arch Phys Med Rehabil
(1995) - et al.
Postoperative and late survival outcomes after major amputationfindings from the Department of Veteran Affairs National Surgical Quality Improvement Program
Surgery
(2001) - et al.
Is lower extremity revascularization worthwhile in patients with end-stage renal disease?
Surgery
(2000) - et al.
Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population
Kidney Int
(1999) - et al.
Prospective comparison of noninvasive techniques for amputation level selection
Am J Surg
(1987) - et al.
TcPO2 as an accurate predictor of therapy in limb salvage
Ann Vasc Surg
(1996) - et al.
A biomechanical model for the transmetatarsal amputation
J Am Podiatr Med Assoc
(1993)
Panmetatarsal head resection and transmetatarsal amputation versus solitary partial ray resection in the neuropathic foot
J Foot Surg
Subtotal pedal amputationsBiomechanical and intraoperative considerations
J Am Podiatr Med Assoc
A historical look at the transmetatarsal amputation and its changing indications
J Am Podiatr Med Assoc
Place of transmetatarsal amputationsa 5-year experience and review of the literature
J R Coll Surg Edinb
Cited by (95)
Morbidity and Mortality of the Transmetatarsal Amputation: A Comparative NSQIP Analysis
2024, Journal of Foot and Ankle SurgeryPresence of a patent pedal arch is the primary predictor of transmetatarsal amputation healing and limb salvage
2023, Journal of Vascular SurgeryReulceration and Reoperation Rates After Central Ray Amputations: A Retrospective Study
2023, Journal of Foot and Ankle SurgeryThe Effect of Remnant Metatarsal Parabola Structure on Transmetatarsal Amputation Primary Healing and Durability
2022, Journal of Foot and Ankle SurgeryAre Transmetatarsal Amputations a Durable Limb Salvage Option? A Single-Institution Descriptive Analysis
2022, Journal of Foot and Ankle SurgeryA Comparison of Adverse Short-Term Outcomes Following Forefoot Amputation Performed on an Inpatient Versus Outpatient Basis
2022, Journal of Foot and Ankle Surgery
- 1
Department of Orthopedics and Podiatric Surgery, Kaiser Permanente Medical Center, Oakland and Richmond, CA; Second-Year Resident, San Francisco Bay Area Foot and Ankle Residency Program, San Francisco, CA
- 2
Department of Orthopedics and Podiatric Surgery, Kaiser Permanente Medical Center, Oakland and Richmond, CA; Staff Podiatric Surgeon, Attending Staff, San Francisco Bay Area Foot and Ankle Residency Program, San Francisco, CA
- 3
Department of Orthopedics and Podiatric Surgery, Kaiser Permanente Medical Center, Walnut Creek, CA; Staff Podiatric Surgeon, Attending Staff, San Francisco Bay Area Foot and Ankle Residency Program, San Francisco, CA
- 4
Department of Orthopedics and Podiatric Surgery, Kaiser Permanente Medical Center, Oakland and Richmond, CA; Staff Podiatric Surgeon, Attending Staff, San Francisco Bay Area Foot and Ankle Residency Program, San Francisco, CA